Stock Ticker

  • Loading stock data...

Johnson & Johnson (NYSE:JNJ) And AstraZeneca (NASDAQ:AZN) To Restart COVID-19 Vaccine Trials

According to Operation Warp Speed head, Johnson & Johnson (NYSE:JNJ) and AstraZeneca (NASDAQ:AZN) could restart their US COVID-19 vaccine trials this week Moncef Slaoui. Halted COVID-19 vaccine trials could restart this week The companies’ COVID-19 vaccine studies were halted due to e-safety concerns after subjects became ill. This slowed the race for a vaccine to […]

Pfizer’s (NYSE:PFE) COVID-19 Trial in Children as Young as 12 Years Draws Mixed Sentiments

Pfizer Inc. (NYSE:PFE) recently announced an expansion to its COVID-19 vaccine trial to include teenagers and children of 12 years. The company is the first drugmaker to include children in their COVID-19 vaccine trials, and this has drawn divided reactions from different people. Pfizer testing vaccine in 3,000 teens The New York Pharms received approval […]

Walmart (NYSE:WMT) Introduces Walmart Insurance Services Offering Medicare Insurance Plans To Seniors And Disabled People

Walmart (NYSE:WMT) has made a move to add Medicare health insurance plans to its list of in-store offerings ahead of the start of the federal program’s Annual Enrolment Period. Walmart launches Walmart Insurance Services for the provision of low-cost insurance plans This is not the first time the retailer has forayed into healthcare as it […]

Pfizer Inc. (NYSE:PFE) And BioNTech SE (NASDAQ:BNTX) Commences COVID-19 Vaccine Trials In Teenagers and Children

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have received approval from the FDA to test their COVID-19 vaccine candidate in children beginning from 12 years. According to the trial’s lead researcher already parents have shown interest in enrolling children in the study. Pfizer and BioNTech start testing COVID-19 vaccine in kids The trial’s expansion to […]

Merck (NYSE:MERK) Quits RSV Vaccine Development With Moderna (NASDAQ:MRNA), But Will Continue Oncology Collaboration

Merck & Co Inc. (NYSE:MERK) is returning all rights to the respiratory syncytial virus (RSV) vaccine to Moderna Inc. (NASDAQ:MRNA) barely after helping take the vaccine into the clinic. The vaccine dubbed mRNA-1172 used Merck’s lipid nanoparticle delivery. Merck to hand over RSV rights to Moderna The pharmaceutical company is doubling down on its in-house […]

Pfizer Inc. (NYSE:PFE) And BioNtech (NASDAQ:BNTX) Partners With Rentschler To Purify mRNA-Based COVID-19 vaccine

Pfizer Inc. (NYSE:PFE) and BioNtech (NASDAQ:BNTX) have partnered with Germany contract development band manufacturing organization, Rentschler Biopharma. The partnership is for the purification process of their mRNA-based SARS-CoV-2 vaccine, BMNT1762b2. Rentschler to purify Pfizer and BioNtech’s COVID-19 vaccine drug substance The companies are conducting late-stage clinical studies of the vaccine and expect to release data […]

Three Stocks to Target the Testing Test (ABT, ALST, QDEL)

It’s all about testing. Short of a vaccine, testing is the high-margin investment from a social survival standpoint for the whole system. Testing, testing, testing. The virus is invisible. It’s impossible to see something that’s invisible, by definition. And it’s impossible to beat something you can’t see. Testing is how we see it, in a […]

Stocks for the Meatless Future (BYND, DGDM, HRL)

According to a Morgan Stanley study, we are headed for a market dominated by millennials – more and more, year after year. The next decade, for stock market participants, will be increasingly dominated by this transition. The data suggests that millennials will inherit over $68 trillion in that time, and much of that will likely […]

It’s Time for Healthcare Stocks 2.0 (TDOC, RXMD, GDRX)

 The shift in the healthcare space over the past six months is perhaps the most striking of all for market participants, from a thematic standpoint. Make no mistake about it: necessity is the mother, father, grandparents, uncle, and aunt of invention. When you really need it, it happens. And that’s what we have in the […]

Merck & Co’s (NYSE:MRK) Lung Cancer Treatment Dominance With Keytruda Challenged By The Likes Of Regeneron

Over the years, Merck & Co’s (NYSE:MRK) blockbuster cancer treatment, Keytruda, has been the standard first-line treatment alternative for most burdensome lung cancers, but this dominance is about to change. Recently at a cancer research conference, several companies challenged the treatment with their won cancer drugs. Merck’s blockbuster cancer treatment could face competition from new […]

Merck (NYSE:MRK) Makes Investment In Seattle Genetics Inc. (NASDAQ:SGEN) For Development Of Ladiratuzumab Vedotin

Merck (NYSE:MRK) has entered a development agreement for Seattle Genetics Inc. (NASDAQ:SGEN) ladiratuzimab vedotin antibody-drug conjugate (ADC). Merck joins Gilead in investing in ADC-developer with a stake in Seattle Genetics The agreement came hours after Gilead Sciences Inc. (NYSE:GILD) announced the acquisition of Immunomedics for $21 billion. The centerpiece of Gilead’s deal is Immunomedic’s anti-Trop-2 […]

Merck & Co., Inc. (NYSE:MRK) Achieves Limited Success Of Steglatro In Reducing The Risk Of Patients With Total Hospitalizations

Merck & Co., Inc.  (NYSE:MRK) reported only limited success in lowering patients’ total hospitalizations with heart failures. According to recent clinical data, Merck’s Steglatro could overall reduce cardiovascular death or total hospitalization risks by just 17% or lower the risk of the patient by 30%. In a statement, Merck said the first hospitalizations rate remains […]

Johnson & Johnson (NYSE:JNJ) Coronavirus Vaccine To Start Late-Stage Trial In September

A coronavirus vaccine being developed by Johnson & Johnson (NYSE:JNJ) is expected to move to late-stage trial in September. In an announcement last week, the company said the phase three study will enroll 60,000 candidates aged 18 and above in around 180 locations in the U.S and abroad. Details released by the company indicate that […]

Stocks to Watch Ahead of the “Twindemic” (APT, LAKE, ALST, DGX)

The pandemic is old news. Scientists and health policy experts are now worried about the rising potential for the “Twindemic” – a coincident crisis involving Covid-19 and influenza primed for emergence this fall as people worry about going to the doctor to get their flu shot. Without widespread adoption of flu shots, the flu could […]

Pfizer Inc.’s (NYSE:PFE) Transforming Into An Integrated and Collaborative Intelligence Company

Over the past decade, Pfizer Inc.’s (NYSE:PFE) data science senior director Chris Kakkanatt has been transforming the company into a collaborative and integrated intelligence entity. This idea has made headlines for years, and with the proliferation of advances and data in machine learning, the objective has become necessary for most organizations. Kakkanatt shared the transformation […]